Bill > SCR66

This resolution designates the first full week of May as "Tardive Dyskinesia Awareness Week" in Delaware, highlighting the critical need for understanding and addressing tardive dyskinesia (TD), a neurological condition characterized by involuntary, repetitive movements that can occur as a side effect of long-term antipsychotic medication use. The resolution emphasizes that approximately 60% of an estimated 800,000 U.S. adults with TD remain undiagnosed, and individuals at higher risk include those over 55, Black individuals, women, and people with mood or substance abuse disorders. By establishing this awareness week, the Delaware General Assembly aims to promote education about TD screening, early detection, and intervention, recognizing that even mild TD symptoms can be stigmatizing and significantly impact a person's physical, social, and emotional well-being. The resolution also supports efforts to encourage healthcare providers, patients, and care partners to understand TD risks, undergo routine screenings, and explore FDA-approved treatment options that can help manage symptoms and improve quality of life for those affected by this condition.

https://legis.delaware.gov/BillDetail?LegislationId=142216